Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | F2 | P00734 | 1/20 | 0.67 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.67 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | APP | P05067 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Benzyloxyaniline SCHEMBL5376217 | 0.98 | MAOB (0.96) | MAOBRAB9AGAAMAPTMAOA | |
| 4-Benzyloxyaniline SCHEMBL371743 | 0.98 | MAOB (0.96) | MAOBRAB9AGAAMAPTMAOA | |
| SCHEMBL5045790 | 0.94 | MAOB (0.89) | MAOBRAB9AGAAMAPTMAOA | |
| SCHEMBL6733465 | 0.94 | MAOB (0.89) | MAOBRAB9AGAAMAPTMAOA | |
| SCHEMBL323938 | 0.91 | MAOB (0.84) | MAOBRAB9AGAAMAPTMAOA | |
| 4-Benzyloxyaniline SCHEMBL8216099 | 0.91 | MAOB (0.82) | MAOBRAB9AGAAMAPTMAOA | |
| 4-Benzyloxyaniline SCHEMBL5571271 | 0.91 | MAOB (0.83) | MAOBRAB9AGAAMAPTMAOA | |
| SCHEMBL31542030 | 0.89 | MAOB (0.80) | MAOBRAB9AGAAMAPTMAOA | |
| SCHEMBL5121663 | 0.89 | MAOB (0.80) | MAOBRAB9AGAAMAPTMAOA | |
| SCHEMBL339813 | 0.89 | LMNA (0.82) | MAOBRAB9AGAAMAPTMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1663 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117645771-A | Solvent-free high-low temperature resistant bulletproof composite matrix resin and preparation method thereof | 上海鑫丰泰新材料科技有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117586207-A | Preparation method of ketoconazole side chain | 浙江东亚药业股份有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-109153655-B | Novel N-acylurea derivatives and compositions comprising the same for preventing or treating cardiovascular diseases | 高丽大学校产学协力团 | 2022-09-30 | — | — | CN | claimed |
| CN-114685788-A | Compound, resin composition, and laminate | 财团法人工业技术研究院 | 2022-07-01 | — | — | CN | claimed |
| US-20220194928-A1 | NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE | UNIV KOREA RES & BUS FOUND (KR) | 2022-06-23 | — | — | US | claimed |
| CN-109705799-B | YASI epoxy organic imide silica gel and preparation method thereof | 东华大学 | 2022-03-18 | — | — | CN | claimed |
| CN-114015044-A | Colorless transparent polyimide resin film and preparation method thereof | 山东中柔新材料有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-109852330-B | 3, 5-diaminobenzoic acid type silicon-containing adhesive and preparation method thereof | 东华大学 | 2022-01-11 | — | — | CN | claimed |
| CN-109722212-B | Imide epoxy organic silica gel and preparation method thereof | 福建省海钛智能科技有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-109852331-B | 3, 5-bis (4-aminophenoxy) benzoic acid type organic silica gel and preparation method thereof | 福建省海钛智能科技有限公司 | 2021-12-28 | — | — | CN | claimed |
| US-6562840-B1 | Non-peptidic inhibitors of proteolytic enzymes such as urokinase | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2003-05-13 | — | — | US | claimed |
| US-20030064991-A1 | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor | MILLENNIUM PHARMACEUTICALS, INC. | 2003-04-03 | — | — | US | claimed |
| WO-2002072549-A1 | FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-09-19 | — | — | WO | claimed |
| WO-2002028353-A2 | PHOSPHATE TRANSPORT INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-04-11 | — | — | WO | claimed |
| EP-1150979-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2001-11-07 | — | — | EP | claimed |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | ILLIG CARL R (US) | 2001-10-18 | — | — | US | claimed |
| US-6291514-B1 | Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2001-09-18 | — | — | US | claimed |
| WO-2000047578-A1 | HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2000-08-17 | — | — | WO | claimed |
| EP-0322643-B1 | MEDICINES CONTAINING AS A MIXTURE INTERFERON AND 1-DESOXY-PIPERIDINOSES, PROCESS FOR THEIR MANUFACTURE AND THEIR USE | BAYER AG (DE) | 1991-07-24 | — | — | EP | claimed |
| US-4729950-A | AROMATIC AMINE, PEROXIDASE, OXIDIZER, 2,3-DIHYDRO-1,4-PHTHALAZINEDIONE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1988-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064991-A1 | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor | ACKR3, CCR5, CXCR4 | MAOB 3386/4885RAB9A 2317/4885GAA 3980/4885 |
| US-20010031781-A1 | Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors | SERPINE1, PRSS3, PRSS2 | MAOB 628/4885RAB9A 1248/4885GAA 533/4885 |
| US-20220194928-A1 | NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE | TLN1, TNNI3, PTK2 | MAOB 3725/4885RAB9A 1229/4885GAA 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.